Medication Nonadherence Ensuring GLP-1s are only prescribed to the appropriate members is proving to be difficult enough, but recent data is also showing that 58% of patients are discontinuing them before reaching meaningful levels of weight loss
It is not approved for human injection under regulatory standards
As always, I welcome your thoughts and would love to hear your experiences in the comments
doi: 10.1038/s41467-021-27766-8, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar] 62.Lee BJ, Lin JS, Lin YC, Lin PT
Both are studied for lipolytic activity, but AOD-9604 has additional published data on cartilage and bone research applications
Benefits emerge within weeks through improved blood sugar stability, reduced appetite dysregulation, and enhanced metabolic flexibilitymeasurable improvements beyond the scale